prazosin has been researched along with Apnea, Sleep in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCall, WV | 1 |
| Chan, E | 1 |
| Steenland, HW | 1 |
| Liu, H | 1 |
| Horner, RL | 1 |
2 other studies available for prazosin and Apnea, Sleep
| Article | Year |
|---|---|
Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Cohort Studies; Humans; Prazosin; Sleep Apnea Syndromes; St | 2020 |
Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.
Topics: Adrenergic alpha-Antagonists; Animals; Hypoglossal Nerve; Male; Microdialysis; Motor Neurons; Prazos | 2006 |